{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:10:16Z","timestamp":1778926216693,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004776","name":"Faculty of Medicine, Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007693","name":"King Chulalongkorn Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xops.2026.101153","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:38:07Z","timestamp":1773333487000},"page":"101153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential Effects of T-Cell Inhibitors and Antimetabolites on Graft Survival in High-Risk Penetrating Keratoplasty: A Tertiary Center Experience"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0741-7154","authenticated-orcid":false,"given":"Susama","family":"Chokesuwattanaskul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanapong","family":"Somkijrungroj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanxiu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vannarut","family":"Satitpitakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101153_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bjo.84.8.813","article-title":"Corneal transplantation: how successful are we?","volume":"84","author":"Waldock","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/08830185.2012.737877","article-title":"Corneal transplantation and immune privilege","volume":"32","author":"Niederkorn","year":"2013","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.xops.2026.101153_bib3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","article-title":"Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib4","series-title":"Ciba Foundation Symposium 15 - Corneal Graft Failure","first-page":"151","article-title":"The allograft rejection reaction: the leading cause of late failure of clinical corneal grafts","author":"Khodadoust","year":"1973"},{"key":"10.1016\/j.xops.2026.101153_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/eye.1995.48","article-title":"Immunosuppression in corneal transplantation","volume":"9","author":"Hill","year":"1995","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101153_bib6","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":"Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101153_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0161-6420(92)31960-8","article-title":"Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry","volume":"99","author":"Williams","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101153_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0000000000000534","article-title":"Management of limbal stem cell deficiency: a historical perspective, past, present, and future","volume":"34","author":"Holland","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.xops.2026.101153_bib9","article-title":"Dysfunctional regulatory T cells in dry eye disease exacerbate corneal allograft rejection","volume":"53","author":"Hua","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101153_bib10","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1097\/TP.0000000000002938","article-title":"High-risk corneal transplantation: recent developments and future possibilities","volume":"103","author":"Armitage","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.xops.2026.101153_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/2008-322X.200156","article-title":"Systemic immunomodulatory strategies in high-risk corneal transplantation","volume":"12","author":"Abud","year":"2017","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.xops.2026.101153_bib12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ajo.2015.06.012","article-title":"Transplant rejection following endothelial keratoplasty and penetrating keratoplasty in the United Kingdom: incidence and survival","volume":"160","author":"Figueiredo","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","article-title":"Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy","volume":"101","author":"Hill","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101153_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.2006.097428","article-title":"Tacrolimus immunosuppression in high-risk corneal grafts","volume":"91","author":"Joseph","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib15","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1038\/s41433-020-01375-z","article-title":"Topical 0.03% tacrolimus versus systemic mycophenolate mofetil as adjuncts to systemic corticosteroids for preventing graft rejection after repeat keratoplasty: one-year results of a randomized clinical trial","volume":"35","author":"Faramarzi","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101153_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00417-015-3200-2","article-title":"Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study","volume":"254","author":"Szaflik","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.14740\/jocmr2326w","article-title":"Systemic immunosuppression in high-risk penetrating keratoplasty: a systematic review","volume":"8","author":"Bali","year":"2016","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.xops.2026.101153_bib18","first-page":"111","article-title":"A primer on model selection using the Akaike Information Criterion","volume":"5","author":"Portet","year":"2020","journal-title":"Infect Dis Model"},{"key":"10.1016\/j.xops.2026.101153_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00003226-200308000-00013","article-title":"Long-term outcome in high-risk corneal transplantation and the influence of HLA-A and HLA-B matching","volume":"22","author":"Bartels","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.xops.2026.101153_bib20","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.4103\/IJO.IJO_2866_22","article-title":"Immunopathogenesis of corneal graft rejection","volume":"71","author":"Maharana","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s40135-017-0119-2","article-title":"Update on the management of high-risk penetrating keratoplasty","volume":"5","author":"Jabbehdari","year":"2017","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.xops.2026.101153_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s40135-022-00298-0","article-title":"Immunosuppressive therapy for high-risk corneal transplant","volume":"10","author":"Azam","year":"2022","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.xops.2026.101153_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2010.04.032","article-title":"Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both","volume":"126","author":"Baumgrass","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xops.2026.101153_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109797","article-title":"Immune tolerance induced in the anterior chamber ameliorates corneal transplant rejection","volume":"257","author":"Sun","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.xops.2026.101153_bib25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/bjophthalmol-2015-307792","article-title":"A comparison of endothelial and penetrating keratoplasty outcomes following failed penetrating keratoplasty: a registry study","volume":"100","author":"Keane","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","article-title":"Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty","volume":"144","author":"Nguyen","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.121.8.1087","article-title":"Risk factors for various causes of failure in initial corneal grafts","volume":"121","author":"Price","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib28","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.transproceed.2007.08.020","article-title":"Epidemiology and risk factors for corneal graft rejection","volume":"39","author":"Sellami","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.xops.2026.101153_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archopht.1981.03930010599002","article-title":"Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment","volume":"99","author":"Alldredge","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2026.101153_bib30","first-page":"368","article-title":"Influence of pretransplant sensitization on the survival of corneal allografts","volume":"23","author":"D'Amaro","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.xops.2026.101153_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0161-6420(00)00544-3","article-title":"The profile of repeated corneal transplantation","volume":"108","author":"Bersudsky","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101153_bib32","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0161-6420(93)31409-0","article-title":"Risk factors of corneal graft failure","volume":"100","author":"Boisjoly","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101153_bib33","article-title":"A novel pharmaceutical protocol for management of immunogenic rejection following repeat penetrating keratoplasty","volume":"49","author":"Nguyen","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101153_bib34","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9570.1000103","article-title":"Management of corneal graft rejection - A case series report and review of the literature","volume":"1","author":"Nguyen","year":"2010","journal-title":"J Clin Exp Ophthalmol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:40:09Z","timestamp":1778924409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666914526000916"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101153","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Effects of T-Cell Inhibitors and Antimetabolites on Graft Survival in High-Risk Penetrating Keratoplasty: A Tertiary Center Experience","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101153"}}